Institution: | 1. National Heart and Lung Institute, Imperial College London, London, UK
Data Science Institute, Imperial College London, London, UK
BenevolentAI, London, UK;2. School of Biological Sciences, University of Manchester, Manchester, UK;3. GSK Respiratory Therapeutic Area Unit, Stevenage, UK;4. Orchard Therapeutics, London, UK;5. Data Science Institute, Imperial College London, London, UK;6. GSK Value Evidence and Outcomes, GSK House, Brentford, UK;7. National Heart and Lung Institute, Imperial College London, London, UK;8. Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden
Sven-Eric Dahlen, On behalf of the U-BIOPRED study group;9. Department of Respiratory Sciences, University of Leicester, Leicester, UK;10. GSK Adaptive Immunity Research Unit, Stevenage, UK;11. School of Biological Sciences, University of Manchester, Manchester, UK
Stewart Bates and Ian M. Adcock contributed equally to this study. |